<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_UCSC_Project skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:UCSC/Project</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV class="button-custom"><DIV class="tiny-little-menu-word-above-button">MENU</DIV></DIV><UL><LI><A href="https://2017.igem.org/Team:UCSC/Judging">JUDGING</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/Notebook">NOTEBOOK</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/Human_Practices">HUMAN PRACTICES</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/Human_Practices">INTRODUCTION</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/Safety">SAFETY</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/Applied_Design">APPLIED DESIGN</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/Engagement">EDUCATION</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/Collaborations">COLLABORATIONS</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/HP/Silver">SILVER</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/HP/Gold_Integrated">GOLD INTEGRATED</A></LI></UL><LI><A href="https://2017.igem.org/Team:UCSC/Project">PROJECT</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/Project">THE PROJECT</A></LI><LI><A href="#">METABOLIC ENGINEERING</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/Acetaminophen">ACETAMINOPHEN</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/B-12">VITAMIN B<SUB>12</SUB></A></LI><LI><A href="https://2017.igem.org/Team:UCSC/Model">MODELING</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/Demonstrate">RESULTS</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/Target-Organism">TARGET ORGANISM</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/Part_Collection">PARTS</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/InterLab">INTERLAB STUDY</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/Team">TEAM</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/Team">MEET THE TEAM</A></LI><LI><A href="https://2017.igem.org/Team:UCSC/Attributions">ATTRIBUTIONS</A></LI><LI><A href="https://2017.igem.org/Team:UCSC">HOME</A></LI><DIV id="page"><CENTER><H1>PROJECT DESCRIPTION</H1><DIV class="text-container"><P><SPAN class="firstword">Malnutrition</SPAN> and inconsistent access to medicine are widespread global problems. While a great deal of progress has been made, micronutrient deficiency remains one of the leading causes of global disease burden, especially in non-industrialized regions<SUP>[1]</SUP>. Our project, <I>Bugs Without Borders</I>, aims to decentralize production of medical and dietary supplements by engineering the alkali photoautotroph, <I>Arthrospira platensis</I>, commonly referred to as Spirulina. <I>A. platensis</I> is the most quintessential organism for growth at “on-site” healthcare facilities due to its modest media cost, alkali growth conditions, and its inherent properties as a nutritional “superfood&quot;<SUP>[2]</SUP>.</P><P>Based on information we gathered through correspondence with international healthcare professionals, acetaminophen and vitamin DMB B<SUB>12</SUB> (the form of vitamin B<SUB>12</SUB> that mammals can absorb) were selected from the World Health Organization (WHO)’s published Essential Medicines List as the most impactful products our photosynthetic “factories” could manufacture<SUP>[3]</SUP>.</P><P>The integration and performance of the genes in acetaminophen production, <I>4ABH</I> and <I>nhoA</I>, and those in vitamin DMB B<SUB>12</SUB> production, <I>ssuE</I> and <I>bluB</I>, were investigated in the model cyanobacteria, <I>Synechococcus elongatus</I> PCC 7942 with the aim of subsequent integration into <I>A. platensis</I> once a genetic system has been studied and established. An <I>in vivo</I> vitamin B<SUB>12</SUB> detection system was also optimized for <I>S. elongatus</I> and <I>E. coli</I> by altering the ribosome binding site on the B<SUB>12</SUB> riboswitch (part BBa_K1913011) and the <I>psbAI</I> (part BBa_K754000) promoter we used for its transcription. In addition, we aim to sequence the entire genome of <I>A. platensis</I> UTEX 2340 to further enable genetic research in this organism and its potential medical applications.</P></DIV><H2>Click on an icon below to learn more about our project!</H2><DIV class="row"><A href="https://2017.igem.org/Team:UCSC/Acetaminophen" class="proj-button"><DIV class="proj-button-desc"><DIV class="overlap-button-text">ACETAMINOPHEN</DIV></DIV></A><A href="https://2017.igem.org/Team:UCSC/B-12" class="proj-button"><DIV class="proj-button-desc"><DIV class="overlap-button-text">VITAMIN B<SUB>12</SUB></DIV></DIV></A><A href="https://2017.igem.org/Team:UCSC/Model" class="proj-button"><DIV class="proj-button-desc"><DIV class="overlap-button-text">MODELING</DIV></DIV></A></DIV><DIV class="row"><A href="https://2017.igem.org/Team:UCSC/Demonstrate" class="proj-button"><DIV class="proj-button-desc"><DIV class="overlap-button-text">RESULTS</DIV></DIV></A><A href="https://2017.igem.org/Team:UCSC/Target-Organism" class="proj-button"><DIV class="proj-button-desc"><DIV class="overlap-button-text">TARGET ORGANISM</DIV></DIV></A><A href="https://2017.igem.org/Team:UCSC/Part_Collection" class="proj-button"><DIV class="proj-button-desc"><DIV class="overlap-button-text">PARTS</DIV></DIV></A><DIV class="container"><DIV class="container"><DIV class="reference-list"><LI>[1] Taylor, D. W., &amp; CIM, F. (2010). Pharmaceutical Access in Least Developed Countries: on-the-ground barriers and industry successes”. Cameron Institute, October.</LI><LI>[2] Spirulina Benefits: 7 Reasons to Try It (&amp; 1 Major Caution) Wellness Mama. (n.d.). Retrieved October 26, 2017, from https://wellnessmama.com/4738/spirulina-benefits/</LI><LI>[3] World  Health  Organization, ed., <I>The  Selection  and  Use  of  Essential  Medicines: report  of  the WHO  Expert  Committee,  2007; (including  the  15th  model  list  of  essential  medicines</I>).  No. 946in WHO Technical Report Series, Geneva:  World Health Organization, 2007. OCLC: 254437808.</LI></DIV></DIV></DIV></DIV></CENTER></DIV><FOOTER><DIV class="footer-box"><DIV class="col-md-5" style="padding-bottom: 40px;"><CENTER><DIV class="footer-section-title">S P O N S O R S</DIV><DIV class="col-md-2" style="padding-bottom: 40px;"><CENTER><DIV class="footer-section-title">S O C I A L </DIV></CENTER></DIV><DIV class="col-md-4" style="padding-bottom: 40px;"><CENTER><DIV class="footer-section-title">C O N T A C T</DIV><DIV class="address-of-our-team"><SPAN>Jack Baskin School of Engineering
    		University of California, Santa Cruz
    		1156 High Street
    		Santa Cruz, California, 95064</SPAN></DIV></CENTER></DIV></CENTER></DIV></DIV></FOOTER></DIV></DIV></DIV></DIV></DIV></BODY></HTML>